Abstract
Immobilized hyaluronidase (nanotechnology method of electron-beam synthesis) exhibited high hepatoprotective activity on the model of Cl4-induced hepatitis. This agent produced anticholestatic, anti-inflammatory, and antisclerotic effects. These effects were shown to accompany stimulation of multipotent bone marrow precursors, mobilization of these cells into the peripheral blood, and cell migration to the target organ increasing the number of parenchymal progenitor cells in the liver. The mechanisms for targeted migration of progenitor cells suggest a decrease in SDF-1 production by bone marrow stromal cells and increase in the synthesis of this factor by microenvironmental cells of the liver tissue.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Biomarkers / metabolism
-
Bone Marrow Cells / cytology
-
Bone Marrow Cells / drug effects
-
Carbon Tetrachloride
-
Cell Movement / drug effects
-
Cellular Microenvironment / drug effects
-
Chemokine CXCL12 / metabolism
-
Cytoprotection*
-
Enzymes, Immobilized / administration & dosage
-
Enzymes, Immobilized / chemistry
-
Enzymes, Immobilized / therapeutic use*
-
Hepatitis, Animal / drug therapy*
-
Hepatitis, Animal / metabolism
-
Hepatitis, Animal / pathology
-
Hyaluronoglucosaminidase / administration & dosage
-
Hyaluronoglucosaminidase / chemistry
-
Hyaluronoglucosaminidase / therapeutic use*
-
Liver / drug effects*
-
Liver / metabolism
-
Liver / pathology
-
Mice
-
Multipotent Stem Cells / cytology
-
Multipotent Stem Cells / drug effects*
-
Nanotechnology
-
Rats
-
Stromal Cells / cytology
-
Stromal Cells / drug effects
Substances
-
Biomarkers
-
Chemokine CXCL12
-
Cxcl12 protein, mouse
-
Enzymes, Immobilized
-
Carbon Tetrachloride
-
Hyaluronoglucosaminidase